Metabolomic Analysis May Provide Non-Invasive Bladder Cancer Surveillance
Jun 22, 2018
A new study identified several metabolites and metabolic indicators as potential biomarkers for recurrence risk in non–muscle-invasive bladder cancer.
Recent Content
Genomic Analyses Reveal Dozens More Prostate Cancer Susceptibility Loci
Jun 22, 2018
A large genomic analysis identified more than 60 new prostate cancer susceptibility loci, including one locus significantly associated with early onset.
MAGE-A3 Immunotherapeutic Fails in Stage III Melanoma
Jun 22, 2018
An antigen-specific immunotherapeutic known as MAGE-A3 was no better than placebo for the adjuvant treatment of stage IIIB or IIIC melanoma.
Higher Indel Counts Linked to Improved OS in RCC
Jun 21, 2018
In RCC patients on anti–PD-1 therapy, besides the indel count link to better OS, baseline tumor infiltration with M2 macrophages predicted improved PFS.
Study IDs Common RCC Subtype in Peds, Young Adults
Jun 21, 2018
This is the first diagnostic classification of RCCs in patients younger than age 30 prospectively registered in a cooperative group clinical study.
Liquid Biopsy to Inform Targeted Tx of CRC
Jun 21, 2018
In this video, Dr. Heinz Josef Lenz outlines the many advantages the development of liquid biopsy is affording cancer patients.
Can Anxiety and Early Life Adversity Affect Ovarian Cancer Outcomes?
Jun 21, 2018
In women with ovarian cancer, those with early life adversity and anxiety had more dysregulation of cortisol, suggesting they may be at risk for more negative outcomes.
FGFR Inhibitor Shows Promise in Advanced Urothelial Carcinoma
Jun 21, 2018
A phase II study found that the FGFR inhibitor erdafitinib yields a good response rate and was well tolerated in patients with urothelial carcinoma and FGFR alterations.
Weighing Immunotherapy/Chemotherapy Options in NSCLC
Jun 20, 2018
Dr. Hossein Borghaei discusses results of the Checkmate 227 trial and its impact on treatment decision-making in NSCLC.
Will Large Gene Study Help to Personalize Thyroid Cancer Tx?
Jun 20, 2018
The study is potentially a “leap forward” in cancer genomics, particularly for subsets of patients with metastatic and anaplastic thyroid cancer.
